These findings underscore the role of MDM4 in modulating GPX4 levels via TRIM21-mediated ubiquitination, thereby impacting ferroptosis sensitivity in p53 mutant colon cancer cells and potentially influencing therapeutic responses. Here, GPX4 is linked to malignant colon neoplasm.